Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.07 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |